Leting Zheng

Statistics

Publications

Citations

370

H-Index

Active since

2016

Affiliations

First Affiliated Hospital of GuangXi Medical University(Current)

Guangxi Medical University

University of Pittsburgh Medical Center

University of Pittsburgh

Leting Zheng is an author at First Affiliated Hospital of GuangXi Medical University specializing in immunology, medicine, and hepatocellular carcinoma pathogenesis.

ORCID

Publications per year

2016–2022

Publications

Interferon regulatory factor 1 (IRF-1) and IRF-2 regulate PD-L1 expression in hepatocellular carcinoma (HCC) cells

Yihe Yan, Leting Zheng, Qiang Du et al. · Cancer Immunology Immunotherapy · 2020 · 100 citations · Full text

Medicine, Molecular Biology, Oncology +11

Interferon regulatory factor 1(IRF-1) activates anti-tumor immunity via CXCL10/CXCR3 axis in hepatocellular carcinoma (HCC)

Yihe Yan, Leting Zheng, Qiang Du et al. · Cancer Letters · 2021 · 95 citations · Full text

Medicine, Cancer Biology, Oncology +14

p53 predominantly regulates IL-6 production and suppresses synovial inflammation in fibroblast-like synoviocytes and adjuvant-induced arthritis

Ting Zhang, Huihua Li, Juan Shi et al. · Arthritis Research & Therapy · 2016 · 67 citations · Full text

Medicine, Immunology, Pathobiology +16

Transitional B cell cytokines predict renal allograft outcomes

Aravind Cherukuri, Alan D. Salama, Rajil Mehta et al. · Science Translational Medicine · 2021 · 48 citations · Full text

Life Sciences, Immunology, Nephrology +17

Interferon regulatory factor 1 (IRF-1) downregulates Checkpoint kinase 1 (CHK1) through miR-195 to upregulate apoptosis and PD-L1 expression in Hepatocellular carcinoma (HCC) cells

Yihe Yan, Leting Zheng, Qiang Du et al. · British Journal of Cancer · 2021 · 35 citations · Full text

Medicine, Cancer Biology, Oncology +17

1–5 of 7